These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Scandinavian recommendations for transfusion medicine]. Eklund J; Jørgensen J; Högman C; Jensson O; Kornstad L Nord Med; 1991; 106(11):299-300. PubMed ID: 1945807 [TBL] [Abstract][Full Text] [Related]
3. [Various methods for good blood supply in Scandinavia]. Oldinger E Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533 [No Abstract] [Full Text] [Related]
4. On the prevention of viral transmitted infections in plasma products. Martin W Dev Biol Stand; 1987; 67():233-6. PubMed ID: 3038637 [TBL] [Abstract][Full Text] [Related]
5. [Can virus safety of blood products be assured?]. Krusius T Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931 [No Abstract] [Full Text] [Related]
6. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119 [TBL] [Abstract][Full Text] [Related]
8. [Establishing a quality assurance system in transfusion medicine exemplified by the Heidelberg University Blood Bank]. Stahl D; Kluge A; Roelcke D Infusionsther Transfusionsmed; 1995 Dec; 22(6):364-77. PubMed ID: 8589598 [TBL] [Abstract][Full Text] [Related]
9. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences. Shulman IA; Jones FS Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224 [TBL] [Abstract][Full Text] [Related]
10. [Transfusion medicine in unified Europe]. Grigutsch V Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():12-5. PubMed ID: 7841774 [TBL] [Abstract][Full Text] [Related]
11. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma. Wagner SJ; Friedman LI; Dodd RY Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274 [No Abstract] [Full Text] [Related]
13. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Van der Bij AK; Coutinho RA; Van der Poel CL Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629 [TBL] [Abstract][Full Text] [Related]
14. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462 [No Abstract] [Full Text] [Related]
15. [Understanding the role of the European public institutions in blood transfusion]. Behr-Gross ME Transfus Clin Biol; 2009 May; 16(2):237-40. PubMed ID: 19443256 [TBL] [Abstract][Full Text] [Related]
16. [Quality assurance management system for therapy with blood and blood products]. Diekamp U Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053 [No Abstract] [Full Text] [Related]
17. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy]. Heim MU Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420 [TBL] [Abstract][Full Text] [Related]
19. Analysis of quality assurance programmes for HIV screening in blood transfusion centres in Delhi. Dhingra-Kumar N; Sharma AK; Madan N Bull World Health Organ; 1997; 75(3):223-8. PubMed ID: 9277009 [TBL] [Abstract][Full Text] [Related]
20. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors. Busch MP Transfusion; 2006 Oct; 46(10):1663-6. PubMed ID: 17002621 [No Abstract] [Full Text] [Related] [Next] [New Search]